MannKind Corporation (MNKD) is the lead sponsor of 3 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 2 Phase 1[2]. MNKD has 6 Form 4 insider filings recorded at the SEC in the past 30 days[4]. SourcesClinicalTrials.gov (2026-04-11) ↗ ClinicalTrials.gov (2026-04-11) ↗ ClinicalTrials.gov (2026-04-11) ↗ SEC EDGAR · 0000899460 (2026-04-11) ↗